company background image
SUNPHARMA logo

Sun Pharmaceutical Industries NSEI:SUNPHARMA Stok Raporu

Son Fiyat

₹1.85k

Piyasa Değeri

₹4.4t

7D

-0.6%

1Y

62.0%

Güncellenmiş

01 Nov, 2024

Veri

Şirket Finansalları +

Sun Pharmaceutical Industries Limited

NSEI:SUNPHARMA Stok Raporu

Piyasa değeri: ₹4.4t

SUNPHARMA Stoklara Genel Bakış

Bir jenerik ilaç şirketi olan Sun Pharmaceutical Industries Limited, Hindistan'da ve uluslararası alanda markalı ve jenerik formülasyonlar ve aktif farmasötik bileşenler (API'ler) geliştirmekte, üretmekte ve pazarlamaktadır.

SUNPHARMA temel anali̇z
Kar Tanesi Skoru
Değerleme1/6
Gelecekteki Büyüme1/6
Geçmiş Performans5/6
Finansal Sağlık6/6
Temettüler4/6

Sun Pharmaceutical Industries Limited Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Sun Pharmaceutical Industries
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı₹1,848.90
52 Haftanın En Yüksek Seviyesi₹1,960.35
52 Haftanın En Düşük Seviyesi₹1,131.50
Beta0.55
11 Aylık Değişim-3.70%
3 Aylık Değişim6.77%
1 Yıllık Değişim62.03%
33 Yıllık Değişim132.43%
5 Yıllık Değişim338.02%
Halka arzdan bu yana değişim90,848.98%

Son Haberler & Güncellemeler

Sun Pharmaceutical Industries Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Oct 31
Sun Pharmaceutical Industries Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

We Ran A Stock Scan For Earnings Growth And Sun Pharmaceutical Industries (NSE:SUNPHARMA) Passed With Ease

Oct 21
We Ran A Stock Scan For Earnings Growth And Sun Pharmaceutical Industries (NSE:SUNPHARMA) Passed With Ease

Recent updates

Sun Pharmaceutical Industries Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Oct 31
Sun Pharmaceutical Industries Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

We Ran A Stock Scan For Earnings Growth And Sun Pharmaceutical Industries (NSE:SUNPHARMA) Passed With Ease

Oct 21
We Ran A Stock Scan For Earnings Growth And Sun Pharmaceutical Industries (NSE:SUNPHARMA) Passed With Ease

Pinning Down Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) P/E Is Difficult Right Now

Aug 24
Pinning Down Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) P/E Is Difficult Right Now

Sun Pharmaceutical Industries Limited Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next

Aug 06
Sun Pharmaceutical Industries Limited Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next

This Is The Reason Why We Think Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) CEO Might Be Underpaid

Jul 30
This Is The Reason Why We Think Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) CEO Might Be Underpaid

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Ticks All The Boxes When It Comes To Earnings Growth

Jun 30
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Ticks All The Boxes When It Comes To Earnings Growth

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet

Jun 12
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 25
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Price Is Out Of Tune With Earnings

May 22
Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Price Is Out Of Tune With Earnings

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet

Mar 13
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet

Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Feb 03
Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today

Jan 05
Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today

Getting In Cheap On Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Is Unlikely

Dec 18
Getting In Cheap On Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Is Unlikely

Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?

Oct 04
Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?

Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?

Jul 03
Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?

We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Can Manage Its Debt With Ease

Jun 15
We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Can Manage Its Debt With Ease

Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) A Risky Investment?

Mar 14
Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) A Risky Investment?

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.50

Feb 03
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.50

These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well

Does This Valuation Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Imply Investors Are Overpaying?

Oct 13
Does This Valuation Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Imply Investors Are Overpaying?

These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely

Sep 04
These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely

Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Aug 05
Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Hissedar Getirileri

SUNPHARMAIN PharmaceuticalsIN Pazar
7D-0.6%1.5%0.004%
1Y62.0%58.7%37.7%

Getiri vs. Endüstri: SUNPHARMA geçen yıl % 58.7 oranında getiri sağlayan Indian Pharmaceuticals sektörünü aştı.

Getiri vs Piyasa: SUNPHARMA geçen yıl % 37.7 oranında getiri sağlayan Indian Piyasasını aştı.

Fiyat Oynaklığı

Is SUNPHARMA's price volatile compared to industry and market?
SUNPHARMA volatility
SUNPHARMA Average Weekly Movement2.1%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.0%

İstikrarlı Hisse Senedi Fiyatı: SUNPHARMA son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: SUNPHARMA 'nin haftalık oynaklığı ( 2% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
198343,000Dilip Shanghviwww.sunpharma.com

Bir jenerik ilaç şirketi olan Sun Pharmaceutical Industries Limited, Hindistan'da ve uluslararası alanda markalı ve jenerik formülasyonlar ve aktif farmasötik bileşenler (API'ler) geliştirmekte, üretmekte ve pazarlamaktadır. Şirket, merkezi sinir sistemi, dermatoloji, kardiyoloji, onkoloji, nöropsikiyatri, gastroenteroloji, anti-enfektifler, diyabetoloji, ağrı/analjezikler, vitaminler/mineraller/besinler, solunum, jinekoloji, üroloji, oftalmoloji, ortopedi, nefroloji, dişçilik ve diğer alanlar dahil olmak üzere çeşitli terapötik alanlarda formülasyonlar sunmaktadır. Anti-kanserler, peptidler, steroidler, hormonlar ve immünosupresan ilaçlar için API'ler sağlamaktadır.

Sun Pharmaceutical Industries Limited Temel Bilgiler Özeti

Sun Pharmaceutical Industries'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
SUNPHARMA temel i̇stati̇sti̇kler
Piyasa değeri₹4.44t
Kazançlar(TTM)₹110.54b
Gelir(TTM)₹503.08b

40.1x

F/K Oranı

8.8x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
SUNPHARMA gelir tablosu (TTM)
Gelir₹503.08b
Gelir Maliyeti₹112.67b
Brüt Kâr₹390.41b
Diğer Giderler₹279.87b
Kazançlar₹110.54b

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)46.07
Brüt Marj77.60%
Net Kâr Marjı21.97%
Borç/Özkaynak Oranı3.0%

SUNPHARMA uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

0.7%

Mevcut Temettü Verimi

34%

Ödeme Oranı